|
 |
| home > pmps > summer 2003 > temperature-controlled distribution in the health care industry - a field of growing importance |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
According to John Taylor, a representative of the Quality Systems Division of the Medicines and Healthcare products Regulatory Agency (MHRA), around one quarter of all significant failures to comply with GDP are due to inadequate control and/or monitoring of the storage and transportation temperatures. While temperature-controlled distribution has always been important to the health care industry, the current biotechnological revolution has further increased the need for protection of thermally unstable products. At the same time, the health care supply chain is becoming more complex, with smaller and more frequent shipments, further increasing the demand on solutions.
Temperature-Sensitive Products are Growing in Importance
Although some observers believe that the rate of growth for the global health care industry will slow down considerably over the next few years, at the same time they agree that some segments will sustain or increase growth rates. One such segment, which is growing faster than the industry in general, is the biotechnology segment. Of the more than 130 biotechnology drugs and vaccines approved by the US Food and Drug Administration (FDA), 70 per cent were approved in the last six years according to the Biotechnology Industry Organisation, 2002. At the same time there are more than 350 biotech drug products and vaccines currently in clinical trials targeting more than 200 diseases according to the Biotechnology Industry Organisation, 2002. Many of these biotechnology drugs are temperature-sensitive. It is estimated that the temperature-sensitive segment is growing at a rate of about 15 per cent per year.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
CPhI Worldwide
5-7 October 2010, Paris, France
CPhI Worldwide was launched in 1990 as an international convention on pharmaceutical ingredients and intermediates. This inaugural CPhI attracted 250 visitors for the 16 exhibitors. Today this has grown to an unrivalled 25,000 industry professionals visiting some 1,430 exhibiting companies from over 125 countries. CPhI is the leading exhibition on pharmaceutical ingredients and allied industries. Each year the exhibition grows larger with exhibitors and visitors conducting significant levels of business at CPhI.
More info >> |
|
 |
News and Press Releases |
 |
PharmaBrand Summit 2010
Top pharmaceutical executives shared best practices at the PharmaBrand Summit
2010, which took place on the 21st to 23rd June 2010 in Monte-Carlo, Monaco
and was organised by Marcus Evans
More info >> |
|
 |
